NasdaqGS - Delayed Quote USD

Surgery Partners, Inc. (SGRY)

26.59 -0.50 (-1.85%)
At close: May 10 at 4:00 PM EDT
27.15 +0.56 (+2.11%)
After hours: May 10 at 7:04 PM EDT
Loading Chart for SGRY
DELL
  • Previous Close 27.09
  • Open 27.31
  • Bid 26.51 x 300
  • Ask 26.63 x 300
  • Day's Range 26.50 - 27.57
  • 52 Week Range 22.05 - 45.79
  • Volume 1,020,288
  • Avg. Volume 965,391
  • Market Cap (intraday) 3.379B
  • Beta (5Y Monthly) 2.76
  • PE Ratio (TTM) 2,659.00
  • EPS (TTM) 0.01
  • Earnings Date Jul 30, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 41.09

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

10,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGRY

Performance Overview: SGRY

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SGRY
16.88%
S&P 500
9.49%

1-Year Return

SGRY
23.59%
S&P 500
26.79%

3-Year Return

SGRY
48.48%
S&P 500
23.39%

5-Year Return

SGRY
156.41%
S&P 500
81.93%

Compare To: SGRY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRY

Valuation Measures

Annual
As of 5/10/2024
  • Market Cap

    3.38B

  • Enterprise Value

    6.35B

  • Trailing P/E

    2.66k

  • Forward P/E

    26.32

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.20

  • Price/Book (mrq)

    1.72

  • Enterprise Value/Revenue

    2.34

  • Enterprise Value/EBITDA

    14.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.02%

  • Return on Assets (ttm)

    4.00%

  • Return on Equity (ttm)

    4.76%

  • Revenue (ttm)

    2.79B

  • Net Income Avi to Common (ttm)

    600k

  • Diluted EPS (ttm)

    0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    185.2M

  • Total Debt/Equity (mrq)

    94.41%

  • Levered Free Cash Flow (ttm)

    149.59M

Research Analysis: SGRY

Company Insights: SGRY

Research Reports: SGRY

People Also Watch